Life Sciences

BDG-Watertown-Life-Sciences

WATERTOWN, MASS. — Boston Development Group (BDG) has received approval from the Watertown Zoning Board of Appeals to move forward with construction of a new life sciences project in the western Boston suburb. Elkus Manfredi Architects is designing the project, which will be built in two phases and will include traditional office, lab and research and development uses. Construction of Phase I, which will feature 200,000 square feet of office and lab space and open green space, is scheduled to begin during the first quarter.

FacebookTwitterLinkedinEmail
3675-Market-Street-Philadelphia

PHILADELPHIA — Colliers International has negotiated a life sciences lease at 3675 Market St. in Philadelphia’s University City neighborhood. Joseph Fetterman and Clifford Brechner of Colliers represented the tenant, gene therapy firm Spirovant Sciences, which will use the space for its expanded headquarters and lab operations, in the lease negotiations. A partnership between Ventas and Wexford Science + Technologies developed the 14-story, 340,000-square-foot building, which houses lab and traditional office space and is located near a variety of retail and restaurant options.

FacebookTwitterLinkedinEmail

CHICAGO — Talis Biomedical Corp. is the latest company to join the tenant lineup at Trammell Crow Co.’s Fulton Labs development in Chicago. Talis will occupy 26,432 square feet of advanced lab, office and chemical storage space. Other tenants at the property include Xeris Pharmaceuticals and Portal Innovations. Fulton Labs totals 725,000 square feet across two buildings, the second of which is slated for completion in early 2022. The first building is immediately available for occupancy. David Saad and Chad Freese of CBRE represented Talis in the lease transaction.

FacebookTwitterLinkedinEmail

DURHAM, N.C. — Trinity Capital Advisors has signed cancer research firm Charles River Laboratories Inc. to a 70,639-square-foot lease for life sciences space within Park Point, an adaptive reuse research and development campus in Durham’s Research Triangle Park. The tenant’s North Carolina Oncology Center of Excellence operation will occupy the space at the park’s Edge West Building. In 2019, Trinity Capital acquired Park Point, a 100-acre office campus situated near Duke University. The ownership is investing $160 million to redevelop the property into a 655,800-square-foot life sciences campus. GRAIL Inc., an early cancer detection firm, will anchor Park Point when it moves into its 200,000-square-foot space in March. Park Point’s amenities will include athletic fields, walking trails, a fitness center, conference and training center, gathering areas and a coffee shop/café. Bill Sandridge, Brendan Callahan and Caitlyn Kinnaird of JLL represented Charles River Laboratories in the lease transaction. Doug Cook of Cushman & Wakefield and William Allen of Trinity Partners handle life sciences and creative office leasing at Park Point, respectively. Trinity Capital is part of Park Point’s ownership group with Starwood Capital Group and Vanderbilt Partners.

FacebookTwitterLinkedinEmail
Lexicon-Pharmaceuticals-The-Woodlands

THE WOODLANDS, TEXAS — Biopharmaceutical firm Lexicon Pharmaceuticals has sold its 260,950-square-foot life sciences campus in The Woodlands, about 30 miles north of Houston. The campus comprises five buildings. Dan Boyles and Jon Silberman of NAI Partners represented Lexicon Pharmaceuticals, which is relocating to another property in The Woodlands, in the deal. The name and representative of the buyer were not disclosed.

FacebookTwitterLinkedinEmail
3200-Walnut-Boulder-CO

BOULDER, COLO. — Tritower Financial Group has completed the disposition of 3200 Walnut, a four-building interconnected campus located at 1825, 1865, 1885 33rd St. and 3200 Walnut St. in Boulder. Invesco Real Estate acquired the asset for an undisclosed price. The tenant — formerly Array BioPharma, which Pfizer acquired in 2019 — has occupied the 151,384-square-foot campus for 19 years. John Jugl of Newmark represented the seller in the deal.

FacebookTwitterLinkedinEmail

BOSTON — Jamestown LP has sold a 50 percent interest in The Innovation & Design Building, a 1.4 million-square-foot office and life sciences property in Boston’s Seaport District. Jamestown originally purchased the building in 2013 and has since invested more than $200 million in its revitalization, with construction of additional office and lab space scheduled to begin later this year. The property now serves as a business hub for companies including Reebok and Autodesk, as well as life sciences users like Ginkgo Bioworks and Living Proof. The buyer was Related Fund Management, the investment management affiliate of Related Cos. and its Boston office, Related Beal. Robert Griffin, Edward Maher, Samantha Hallowell and Dominick Romano of Newmark brokered the deal, which represents a $710 million recapitalization.

FacebookTwitterLinkedinEmail

BOSTON — BioMed Realty has acquired the former headquarters of John Hancock Life Insurance Co. in Boston and plans to convert the 14-story building into a life sciences facility. The building, which is located at 601 Congress St. in the Seaport District, features floor plates ranging from 19,000 to 50,000 square feet, 11 elevators, 14-foot ceilings on the second and third floors, 12-foot ceilings on the fifth through 14th floors, a fitness center, six-story atrium, two rooftop decks, conference center and a café. The property has sat vacant since 2018 when John Hancock consolidated its Boston offices to its building in the Back Bay district. BioMed, a Blackstone subsidiary, acquired the 485,000-square-foot property from an affiliate of Manulife Investment Management for an undisclosed price. Robert Griffin, Edward Maher, Matthew Pullen and Samantha Hallowell of Newmark brokered the deal. BioMed says the building is ideal for the planned conversion due to its mechanical and structural infrastructure, collaborative meeting areas and strong visual identity. BioMed is yet to select a general contractor for the conversion project, which the San Diego-based company expects to deliver in the second half of 2022. The Seaport District is situated along the Boston Main Channel and is …

FacebookTwitterLinkedinEmail
Teleflex-Knitting-Mills-Wyomissing-Pennsylvania

WYOMISSING, PA. — Philadelphia-based Equus Capital Partners has sold a three-building, 262,615-square-foot life sciences portfolio in Wyomissing, located just outside Reading in Berks County. An affiliate of Miami-based Kawa Capital Management purchased the portfolio for an undisclosed price. The buildings are located within the 53-acre Knitting Mills campus and house office and lab space that is leased to tenants such as UGI Energy Services, Teleflex and Tower Health. The site was originally built in the early 20th century as a manufacturing hub for The Berkshire Knitting Mills. Equus bought the site in 2016 with plans to redevelop it into a life sciences campus.

FacebookTwitterLinkedinEmail
111-Ideation-Way-Nutley-New-Jersey

NUTLEY, N.J. — Prism Capital Partners has sold 111 Ideation Way, a 157,000-square-foot life sciences building in the Northern New Jersey city of Nutley. The building, which was fully leased at the time of sale, is part of Prism’s 116-acre ON3 campus that is a redevelopment of the former North American headquarters site of Swiss pharmaceutical company Hoffman-La Roche. Prism Capital sold the asset to Chicago-based Harrison Street for an undisclosed price. Andrew Merin, David Bernhaut, Gary Gabriel, Frank DiTommaso Kyle Schmidt, John Alascio and Sridhar Vankayala of Cushman & Wakefield brokered the deal.

FacebookTwitterLinkedinEmail